37 results
Page 2 of 2
424B5
18m7kz3jkvkvw2zpntny
10 Jun 20
Prospectus supplement for primary offering
12:00am
424B5
lbwq0n1
8 Jun 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.2
ky5 8rmbxsd
2 Apr 20
Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies
4:55pm
10-K
6tknog7
17 Mar 14
Annual report
12:00am
10-Q
theyvp
13 Nov 13
Quarterly report
12:00am
424B4
wk6pkbhab
1 Oct 13
Prospectus supplement with pricing info
12:00am
DRS/A
g7f0gai2et
29 Jul 13
Draft registration statement (amended)
12:00am